H.R. 6567 · 110th Congress
Pulmonary Fibrosis Research Enhancement Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
BairdSponsor30 cosponsors · 18 D, 12 R
R
Castle
ND
R
Deal
JG
R
Gerlach
JH
D
Harman
MK
D
Kaptur
MK
R
Kirk
SL
R
LaTourette
JS
D
Speier
CY
R
Young
RW
D
Wexler
VG
R
Goode
BG
D
Gordon
TL
R
Latham
JM
D
Marshall
FW
R
Wolf
RB
R
Bishop
EB
D
Blumenauer
DP
D
Price
JT
D
Tierney
TA
D
Allen
DD
D
DeGette
BG
R
Goodlatte
DC
D
Cardoza
ZL
D
Lofgren
HW
D
Waxman
PW
D
Welch
BP
D
Pascrell
TP
R
Platts
JS
D
Sarbanes
ET
D
Towns9 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Pulmonary Fibrosis Research Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) develop a system to collect data on pulmonary fibrosis and other interstitial lung diseases; (2) establish the National PF…
What it does: CRS summary · Introduced in House · Jul 22, 2008
Pulmonary Fibrosis Research Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) develop a system to collect data on pulmonary fibrosis and other interstitial lung diseases; (2) establish the National PF Registry; and (3) establish the National Pulmonary Fibrosis Advisory Board.
Allows the Secretary, acting through the Director of the CDC, to provide for the collection, analysis, and reporting of data on pulmonary fibrosis and other interstitial lung diseases that can be confused with, misdiagnosed as, and progress to pulmonary fibrosis.
Requires the Secretary, in developing the Registry, to: (1) expand and coordinate existing data and surveillance systems, surveys, registries, and other federal public health and environmental infrastructure; and (2) provide for research access to pulmonary fibrosis data.
Directs the Secretary to ensure that epidemiological and other types of information are made available to the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA).
Requires the Director of the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate Institute pulmonary fibrosis research activities.
Requires the Director of CDC to prepare the National Pulmonary Fibrosis Action Plan.
Requires the Secretary to: (1) convene a summit of individuals with expertise in research and care of pulmonary fibrosis to provide a detailed overview of NIH research activities and discuss potential collaborations between NIH and other federal health agencies; and (2) make information about NIH activities relating to pulmonary fibrosis publicly available.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Pulmonary Fibrosis Research Enhancement Act
Latest action (Jul 22, 2008): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jul 22, 2008
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.